Delivery Order SPE2DB24D3015-SPE2DB25FGAWM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of 500 tablets of Topiramate 25 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. Valued at $42,512.13 with a firm fixed price structure, this competitively awarded delivery order is non-set-aside and scheduled for completion by September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 100 mg, a generic anticonvulsant medication commonly used for seizure disorders and migraine prevention. This competitively awarded, firm fixed-price delivery order was established on October 15, 2025, with an ultimate completion date of October 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract contains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Topiramate 50 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. This firm fixed-price delivery order, valued at $1,005.84, is set to be completed by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a contract ceiling value of $7,555.16. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 25, 2025, by the Defense Logistics Agency for 500 tablets of Topiramate 25 mg, a generic anticonvulsant and migraine prevention medication commonly used in military and veteran healthcare systems. The delivery order, valued at $19,617.80 with firm fixed pricing, is non-competitive and was issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units. This non-set-aside, competitively awarded contract carries a ceiling value of $59,501.78 under a firm fixed-price arrangement, with an ultimate completion date of August 27, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $5,177.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Topiramate 25 mg. This contract, which was competitively awarded without set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of June 6, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract derived from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $7,263.89 and a firm fixed price arrangement. This delivery order represents a non-competitive set-aside award and is scheduled for completion by August 7, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters....
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAWMDelivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of 500 tablets of Topiramate 25 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. This firm fixed-price delivery order, valued at $7,673.09 with completion scheduled for September 8, 2025, was issued without set-aside designation, reflecting open competition among qualified pharmaceutical vendors. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, supplying pharmaceuticals and medical commodities to support military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements on a competitive basis, ranging from small-value pharmaceutical orders to substantial medical supply deliveries. This delivery order exemplifies the company's role in providing essential generic medications to federal healthcare programs through the DLA's comprehensive global pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/5/25 |